A detailed history of Harrison & CO Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Harrison & CO Wealth Management, LLC holds 8,598 shares of NVO stock, worth $751,207. This represents 1.13% of its overall portfolio holdings.

Number of Shares
8,598
Previous 8,708 1.26%
Holding current value
$751,207
Previous $868,000 33.99%
% of portfolio
1.13%
Previous 0.92%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023

SELL
$102.55 - $135.33 $11,280 - $14,886
-110 Reduced 1.26%
8,598 $0
Q3 2022

Oct 18, 2022

SELL
$95.28 - $116.93 $66,219 - $81,266
-695 Reduced 7.39%
8,708 $868,000
Q2 2022

Jul 11, 2022

BUY
$103.24 - $121.81 $3,406 - $4,019
33 Added 0.35%
9,403 $1.05 Million
Q1 2022

Apr 18, 2022

SELL
$93.1 - $112.54 $41,801 - $50,530
-449 Reduced 4.57%
9,370 $1.04 Million
Q4 2021

Jan 31, 2022

BUY
$95.88 - $117.08 $941,445 - $1.15 Million
9,819 New
9,819 $1.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Harrison & CO Wealth Management, LLC Portfolio

Follow Harrison & CO Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harrison & CO Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harrison & CO Wealth Management, LLC with notifications on news.